Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines.

Sun Y, Li Q, Gui H, Xu DP, Yang YL, Su DF, Liu X.

Cell Res. 2013 Nov;23(11):1270-83. doi: 10.1038/cr.2013.116. Epub 2013 Aug 27.

2.

Protective role of the cholinergic anti-inflammatory pathway in a mouse model of viral myocarditis.

Cheng Z, Li-Sha G, Jing-Lin Z, Wen-Wu Z, Xue-Si C, Xing-Xing C, Yue-Chun L.

PLoS One. 2014 Nov 14;9(11):e112719. doi: 10.1371/journal.pone.0112719. eCollection 2014.

3.

Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis.

Peña G, Cai B, Liu J, van der Zanden EP, Deitch EA, de Jonge WJ, Ulloa L.

Eur J Immunol. 2010 Sep;40(9):2580-9. doi: 10.1002/eji.201040540.

4.
5.

IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes.

Rossato M, Curtale G, Tamassia N, Castellucci M, Mori L, Gasperini S, Mariotti B, De Luca M, Mirolo M, Cassatella MA, Locati M, Bazzoni F.

Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):E3101-10. doi: 10.1073/pnas.1209100109. Epub 2012 Oct 15.

6.

Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling.

Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, Ochani M, Ochani K, Yang LH, Hudson L, Lin X, Patel N, Johnson SM, Chavan S, Goldstein RS, Czura CJ, Miller EJ, Al-Abed Y, Tracey KJ, Pavlov VA.

Mol Med. 2008 Sep-Oct;14(9-10):567-74. doi: 10.2119/2008-00079.Parrish.

7.

Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.

Pavlov VA, Parrish WR, Rosas-Ballina M, Ochani M, Puerta M, Ochani K, Chavan S, Al-Abed Y, Tracey KJ.

Brain Behav Immun. 2009 Jan;23(1):41-5. doi: 10.1016/j.bbi.2008.06.011. Epub 2008 Jun 27.

8.

Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.

Xiang H, Hu B, Li Z, Li J.

Inflammation. 2014 Oct;37(5):1763-70. doi: 10.1007/s10753-014-9906-1.

PMID:
24803295
9.
10.

α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.

Kox M, Pompe JC, Peters E, Vaneker M, van der Laak JW, van der Hoeven JG, Scheffer GJ, Hoedemaekers CW, Pickkers P.

Br J Anaesth. 2011 Oct;107(4):559-66. doi: 10.1093/bja/aer202. Epub 2011 Jul 18.

11.

Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3.

Chen Q, Wang H, Liu Y, Song Y, Lai L, Han Q, Cao X, Wang Q.

PLoS One. 2012;7(8):e42971. doi: 10.1371/journal.pone.0042971. Epub 2012 Aug 24.

12.

Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.

Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der Poll T.

Shock. 2007 Dec;28(6):700-3.

PMID:
17621262
13.

Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis.

Bruchfeld A, Goldstein RS, Chavan S, Patel NB, Rosas-Ballina M, Kohn N, Qureshi AR, Tracey KJ.

J Intern Med. 2010 Jul;268(1):94-101. doi: 10.1111/j.1365-2796.2010.02226.x. Epub 2010 Feb 18.

14.

Upregulating nonneuronal cholinergic activity decreases TNF release from lipopolysaccharide-stimulated RAW264.7 cells.

Lv Y, Hu S, Lu J, Dong N, Liu Q, Du M, Zhang H.

Mediators Inflamm. 2014;2014:873728. doi: 10.1155/2014/873728. Epub 2014 Mar 9.

15.
16.

The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE.

Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, Yang L, Valdés-Ferrer SI, Patel NB, Chavan S, Al-Abed Y, Yang H, Tracey KJ.

Mol Med. 2009 Jul-Aug;15(7-8):195-202. doi: 10.2119/molmed.2009.00039. Epub 2009 Apr 27.

17.

Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation.

Báez-Pagán CA, Delgado-Vélez M, Lasalde-Dominicci JA.

J Neuroimmune Pharmacol. 2015 Sep;10(3):468-76. doi: 10.1007/s11481-015-9601-5. Epub 2015 Apr 14. Review.

PMID:
25870122
18.

Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting α7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats.

Zhang W, Sun Q, Gao X, Jiang Y, Li R, Ye J.

PLoS One. 2013 Jun 28;8(6):e66895. doi: 10.1371/journal.pone.0066895. Print 2013.

19.

MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages.

Jiang P, Liu R, Zheng Y, Liu X, Chang L, Xiong S, Chu Y.

Exp Cell Res. 2012 Jun 10;318(10):1175-84. doi: 10.1016/j.yexcr.2012.03.018. Epub 2012 Mar 27.

PMID:
22483937
20.

STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.

Samavati L, Rastogi R, Du W, Hüttemann M, Fite A, Franchi L.

Mol Immunol. 2009 May;46(8-9):1867-77. doi: 10.1016/j.molimm.2009.02.018. Epub 2009 Mar 18.

PMID:
19299019
Items per page

Supplemental Content

Write to the Help Desk